Carestream Molecular Imaging Announces Availability of New Bone Density Image Analysis Software

Carestream Health, Inc.Carestream Molecular Imaging, a division of Carestream Health, Inc., announced worldwide availability of a new Bone Density Software application that performs bone density analysis of small animals in vivo and measures mineral density of specimens in vitro. The software can expedite calculation and reporting for numerous applications ranging from the study of diseases of the bone such as arthritis and osteoporosis to the efficacy of drugs and other treatment options that may affect bone mineral and other densities.

Offered as an optional module for Carestream Molecular Imaging Software used by tens of thousands of researchers worldwide, the new application delivers a sophisticated numerical analysis that goes beyond traditional bone density software tools. It uses a cylindrical model that provides measurements not only of the density of the bone, but also of the bone marrow, the size of the bone and the thickness of the bone wall - all important parameters for tracking and monitoring disease development.

Unlike whole body bone density measurement systems, which often make it difficult to interpret global measurements, Carestream Molecular Imaging's Bone Density Software utilizes low-dose "soft" x-rays imaged with high spatial resolution-allowing researchers to measure specific segments of single long bones.

"A distinct advantage of our new software is that users are able to very precisely analyze specific bone density changes," said Bill McLaughlin, Director of Research and Advanced Applications, Carestream Molecular Imaging. "This new method is not only more accurate, it is also more efficient and can contribute to early detection and monitoring of disease studies, developmental abnormalities and therapeutic treatments."

The software is designed for use with Carestream Molecular Imaging’s In-Vivo Imaging FX Pro, Multispectral FX and DXS 4000 Pro Systems. The Imaging System FX Pro and Multispectral FX combine high-sensitivity optical molecular imaging and high-resolution digital x-ray to deliver precise anatomical localization of molecular and cellular biomarkers, while the DXS 4000 produces high-resolution radiographs of medical, life science and material science research specimens. With exceptional resolution of up to 25 line pairs per millimeter without geometric magnification, the DXS 4000 system offers the highest resolution available for digital specimen radiography.

Availability
Carestream Molecular Imaging's Bone Density Software is currently available worldwide. For more information, visit http://mi.carestreamhealth.com.

Related news articles:

About Carestream Molecular Imaging
Carestream Molecular Imaging group, a division of Carestream Health, Inc., develops and markets high performance digital imaging systems, imaging agents, film and accessories under the KODAK brand for the life science research, specimen radiography and drug discovery/development market segments.

About Carestream Health, Inc.
Formed in 2007, Carestream Health, Inc., is a worldwide provider of dental and medical imaging systems and healthcare IT solutions; molecular imaging systems for the life science research and drug discovery/development market segments; and x-ray film and digital x-ray products for the non-destructive testing market. For more information about the company's broad portfolio of products, solutions and services, please contact your Carestream Health representative or visit www.carestreamhealth.com.

Most Popular Now

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

GPT-4 Matches Radiologists in Detecting …

Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology reports, according to research published in Radiology, a journal of the Radiological Society of North America...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

Experts Propose Specific and Suited Guid…

Current Artificial Intelligence (AI) models for cancer treatment are trained and approved only for specific intended purposes. GMAI models, in contrast, can handle a wide range of medical data including...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...